Chery G, Kamp N, Kosinski AS, et al. - Researchers examined the prognostic worth of myocardial fibrosis as evaluated by late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging in patients experiencing ischemic cardiomyopathy (ICM) for ventricular tachyarrhythmia, sudden cardiac death (SCD), or all-cause death. They explored Pubmed and Embase to identify the relevant and eligible studies. Overall eight studies with 1,085 participants were examined. Findings are suggestive of the high prognostic worth of LGE in predicting adverse consequences in patients suffering from ICM. Also, LGE may afford useful information for clinical decision making associated with SCD prevention. The observations of this study show that current risk stratification, prognostication, and selection of patients with ICM for implantable cardioverter/defibrillator therapy may be improved by LGE.